Loading…
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
Kuruvilla, John, Ramchandren, Radhakrishnan, Santoro, Armando, Paszkiewicz-Kozik, Ewa, Gasiorowski, Robin, Johnson, Nathalie A, Fogliatto, Laura Maria, Goncalves, Iara, de Oliveira, Jose S R, Buccheri, Valeria, Perini, Guilherme F, Goldschmidt, Neta, Kriachok, Iryna, Dickinson, Michael, Komarnicki, Mieczyslaw, McDonald, Andrew, Ozcan, Muhit, Sekiguchi, Naohiro, Zhu, Ying, Nahar, Akash, Marinello, Patricia, Zinzani, Pier Luigi
Published in The lancet oncology (01.04.2021)
Published in The lancet oncology (01.04.2021)
Get full text
Journal Article
Loading…
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Ansell, Stephen M., Radford, John, Connors, Joseph M., Długosz-Danecka, Monika, Kim, Won-Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Hutchings, Martin, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J.
Published in The New England journal of medicine (28.07.2022)
Published in The New England journal of medicine (28.07.2022)
Get full text
Journal Article
Loading…
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Armand, Philippe, Engert, Andreas, Younes, Anas, Fanale, Michelle, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John M., Collins, Graham P., Ramchandren, Radhakrishnan, Cohen, Jonathon B., De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J., Trneny, Marek, Shipp, Margaret A., Kato, Kazunobu, Sumbul, Anne, Farsaci, Benedetto, Ansell, Stephen M.
Published in Journal of clinical oncology (10.05.2018)
Published in Journal of clinical oncology (10.05.2018)
Get full text
Journal Article
Loading…
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL
Goy, Andre, Ramchandren, Radhakrishnan, Ghosh, Nilanjan, Munoz, Javier, Morgan, David S., Dang, Nam H., Knapp, Mark, Delioukina, Maria, Kingsley, Edwin, Ping, Jerry, Beaupre, Darrin M., Neuenburg, Jutta K., Ruan, Jia
Published in Blood (26.09.2019)
Published in Blood (26.09.2019)
Get full text
Journal Article
Loading…
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Roemer, Margaretha G.M., Redd, Robert A., Cader, Fathima Zumla, Pak, Christine J., Abdelrahman, Sara, Ouyang, Jing, Sasse, Stephanie, Younes, Anas, Fanale, Michelle, Santoro, Armando, Zinzani, Pier Luigi, Timmerman, John, Collins, Graham P., Ramchandren, Radhakrishnan, Cohen, Jonathon B., De Boer, Jan Paul, Kuruvilla, John, Savage, Kerry J., Trneny, Marek, Ansell, Stephen, Kato, Kazunobu, Farsaci, Benedetto, Sumbul, Anne, Armand, Philippe, Neuberg, Donna S., Pinkus, Geraldine S., Ligon, Azra H., Rodig, Scott J., Shipp, Margaret A.
Published in Journal of clinical oncology (01.04.2018)
Published in Journal of clinical oncology (01.04.2018)
Get full text
Journal Article
Loading…
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
Ramchandren, Radhakrishnan, Domingo-Domènech, Eva, Rueda, Antonio, Trněný, Marek, Feldman, Tatyana A., Lee, Hun Ju, Provencio, Mariano, Sillaber, Christian, Cohen, Jonathon B., Savage, Kerry J., Willenbacher, Wolfgang, Ligon, Azra H., Ouyang, Jing, Redd, Robert, Rodig, Scott J., Shipp, Margaret A., Sacchi, Mariana, Sumbul, Anne, Armand, Philippe, Ansell, Stephen M.
Published in Journal of clinical oncology (10.08.2019)
Published in Journal of clinical oncology (10.08.2019)
Get full text
Journal Article
Loading…
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Pro, Barbara, Advani, Ranjana, Brice, Pauline, Bartlett, Nancy L., Rosenblatt, Joseph D., Illidge, Tim, Matous, Jeffrey, Ramchandren, Radhakrishnan, Fanale, Michelle, Connors, Joseph M., Yang, Yin, Sievers, Eric L., Kennedy, Dana A., Shustov, Andrei
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Loading…
Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
Goy, Andre, Sinha, Rajni, Williams, Michael E., Kalayoglu Besisik, Sevgi, Drach, Johannes, Ramchandren, Radhakrishnan, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Witzig, Thomas E.
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Loading…
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Younes, Anas, Gopal, Ajay K., Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Ramchandren, Radhakrishnan, Bartlett, Nancy L., Cheson, Bruce D., de Vos, Sven, Forero-Torres, Andres, Moskowitz, Craig H., Connors, Joseph M., Engert, Andreas, Larsen, Emily K., Kennedy, Dana A., Sievers, Eric L., Chen, Robert
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Loading…
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma
Herrera, Alex F., Goy, Andre, Mehta, Amitkumar, Ramchandren, Radhakrishnan, Pagel, John M., Svoboda, Jakub, Guan, Shanhong, Hill, John S., Kwei, Kevin, Liu, Emily A., Phillips, Tycel
Published in American journal of hematology (01.01.2020)
Published in American journal of hematology (01.01.2020)
Get full text
Journal Article
Loading…
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma
Timmerman, John, Herbaux, Charles, Ribrag, Vincent, Zelenetz, Andrew D., Houot, Roch, Neelapu, Sattva S., Logan, Theodore, Lossos, Izidore S., Urba, Walter, Salles, Gilles, Ramchandren, Radhakrishnan, Jacobson, Caron, Godwin, John, Carpio, Cecilia, Lathers, Deanne, Liu, Yali, Neely, Jaclyn, Suryawanshi, Satyendra, Koguchi, Yoshinobu, Levy, Ronald
Published in American journal of hematology (01.05.2020)
Published in American journal of hematology (01.05.2020)
Get full text
Journal Article
Loading…
Editorial: Advances in the treatment of Hodgkin lymphoma
Mei, Matthew, Perini, Guilherme, Ramchandren, Radhakrishnan
Published in Frontiers in oncology (28.02.2023)
Published in Frontiers in oncology (28.02.2023)
Get full text
Journal Article
Loading…
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses
Landsburg, Daniel J., Barta, Stefan K., Ramchandren, Radhakrishnan, Batlevi, Connie, Iyer, Swaminathan, Kelly, Kevin, Micallef, Ivana N., Smith, Sonali M., Stevens, Don A., Alvarez, Mariano, Califano, Andrea, Shen, Yao, Bosker, Gideon, Parker, Jefferson, Soikes, Raul, Martinez, Elizabeth, Roemeling, Reinhard, Martell, Robert E., Oki, Yasuhiro
Published in British journal of haematology (01.10.2021)
Published in British journal of haematology (01.10.2021)
Get full text
Journal Article
Loading…
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Straus, David J, Długosz-Danecka, Monika, Connors, Joseph M, Alekseev, Sergey, Illés, Árpád, Picardi, Marco, Lech-Maranda, Ewa, Feldman, Tatyana, Smolewski, Piotr, Savage, Kerry J, Bartlett, Nancy L, Walewski, Jan, Ramchandren, Radhakrishnan, Zinzani, Pier Luigi, Hutchings, Martin, Munoz, Javier, Lee, Hun Ju, Kim, Won Seog, Advani, Ranjana, Ansell, Stephen M, Younes, Anas, Gallamini, Andrea, Liu, Rachael, Little, Meredith, Fenton, Keenan, Fanale, Michelle, Radford, John
Published in The Lancet. Haematology (01.06.2021)
Published in The Lancet. Haematology (01.06.2021)
Get more information
Journal Article
Loading…
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study
Wang, Michael, Ramchandren, Radhakrishnan, Chen, Robert, Karlin, Lionel, Chong, Geoffrey, Jurczak, Wojciech, Wu, Ka Lung, Bishton, Mark, Collins, Graham P., Eliadis, Paul, Peyrade, Frédéric, Lee, Yihua, Eckert, Karl, Neuenburg, Jutta K., Tam, Constantine S.
Published in Journal of hematology and oncology (30.10.2021)
Published in Journal of hematology and oncology (30.10.2021)
Get full text
Journal Article
Loading…
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation
Gopal, Ajay K., Ramchandren, Radhakrishnan, O'Connor, Owen A., Berryman, Robert B., Advani, Ranjana H., Chen, Robert, Smith, Scott E., Cooper, Maureen, Rothe, Achim, Matous, Jeffrey V., Grove, Laurie E., Zain, Jasmine
Published in Blood (19.07.2012)
Published in Blood (19.07.2012)
Get full text
Journal Article
Loading…
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma
Dang, Nam H., Ogura, Michinori, Castaigne, Sylvie, Fayad, Luis E., Jerkeman, Mats, Radford, John, Pezzutto, Antonio, Bondarenko, Igor, Stewart, Douglas A., Shnaidman, Michael, Sullivan, Sharon, Vandendries, Erik, Tobinai, Kensei, Ramchandren, Radhakrishnan, Hamlin, Paul A., Giné, Eva, Ando, Kiyoshi
Published in British Journal of Haematology (01.08.2018)
Published in British Journal of Haematology (01.08.2018)
Get full text
Journal Article
Loading…
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy
Carreau, Nicole A., Pail, Orrin, Armand, Philippe, Merryman, Reid, Advani, Ranjana H., Spinner, Michael A., Herrera, Alex, Chen, Robert, Tomassetti, Sarah, Ramchandren, Radhakrishnan, Hamid, Muhammad S., Assouline, Sarit, Santiago, Raoul, Wagner‐Johnston, Nina, Paul, Suman, Svoboda, Jakub, Bair, Steven, Barta, Stefan, Liu, Yang, Nathan, Sunita, Karmali, Reem, Burkart, Madelyn, Torka, Pallawi, David, Kevin, Wei, Catherine, Lansigan, Frederick, Emery, Lukas, Persky, Daniel, Smith, Sonali, Godfrey, James, Chavez, Julio, Xia, Yuhe, Troxel, Andrea B., Diefenbach, Catherine
Published in The oncologist (Dayton, Ohio) (01.10.2020)
Published in The oncologist (Dayton, Ohio) (01.10.2020)
Get full text
Journal Article
Loading…
Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy
Carreau, Nicole A., Armand, Philippe, Merryman, Reid W., Advani, Ranjana H., Spinner, Michael A., Herrera, Alex F., Ramchandren, Radhakrishnan, Hamid, Muhammad S., Assouline, Sarit, Santiago, Raoul, Wagner‐Johnston, Nina, Paul, Suman, Svoboda, Jakub, Bair, Steven M., Barta, Stefan K., Nathan, Sunita, Karmali, Reem, Torka, Pallawi, David, Kevin, Lansigan, Frederick, Persky, Daniel, Godfrey, James, Chavez, Julio C., Xia, Yuhe, Diefenbach, Catherine
Published in British journal of haematology (01.10.2020)
Published in British journal of haematology (01.10.2020)
Get full text
Journal Article
Loading…
Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis
Xu, Mina L, Gabali, Ali, Hsi, Eric D, Fedoriw, Yuri, Vij, Kiran, Salama, Mohamed E, Ramchandren, Radhakrishnan, O'Malley, Dennis, Wick, Mark R, Battistella, Maxime, Gru, Alejandro A
Published in The American journal of surgical pathology (01.02.2020)
Published in The American journal of surgical pathology (01.02.2020)
Get more information
Journal Article